If you have a senior dog, you probably know the signs. The hesitation before jumping onto the couch they used to leap onto without thinking. The stiffness after a nap that takes a few minutes to shake off. The tail-wagging enthusiasm that’s still clearly there, but the body that doesn’t quite cooperate the way it used to. Arthritis is behind most of these changes, and it affects more dogs than most pet owners realize.
Red light therapy has been gaining serious attention as a non-drug option for managing canine arthritis — not from the wellness fringe, but from veterinary rehab specialists, clinical researchers, and increasingly, from the vets who treat the dogs you’re watching slow down. Here’s what the science actually says, and what it means in practice.
How Common Is Arthritis in Dogs?
More common than most people assume. According to the American College of Veterinary Surgeons, approximately one in five dogs will develop arthritis in their lifetime — and in dogs over seven years old, that number rises to roughly one in two. It’s not a condition that only affects the very elderly or certain breeds; it can develop from genetics, previous injuries, excessive weight, or simply the cumulative wear of a life well-lived.
The challenge with canine arthritis is that dogs are remarkably good at hiding pain. The behavioural changes that signal arthritis — reluctance to climb stairs, sleeping more, reduced play, subtle changes in gait — are often attributed to “getting old” rather than a treatable condition. By the time owners notice significant changes, the joint damage is often already significant.
What Is Red Light Therapy and How Does It Work?
Red light therapy — also called photobiomodulation (PBM), low-level laser therapy, or cold laser therapy — uses specific wavelengths of red and near-infrared light to penetrate tissue and stimulate biological activity at the cellular level. It doesn’t produce heat in the tissue (hence “cold” laser) and causes no discomfort. Most dogs find sessions calming.
The mechanism that makes it useful for arthritis centres on the mitochondria. When light at the appropriate wavelength is absorbed by cytochrome c oxidase — an enzyme in the mitochondria — it increases ATP (cellular energy) production. This gives damaged cells the energy to reduce inflammation, repair tissue, and improve blood flow to the affected joint. The result, supported by multiple clinical studies, is measurable reduction in pain and improvement in mobility.
Visible red light (typically around 635nm) addresses superficial tissues and improves circulation. Near-infrared light (around 850nm) penetrates deeper — reaching joints, muscle tissue, and bone — which is what makes it relevant for arthritis rather than just surface-level concerns.
What Does the Evidence Actually Say?
The evidence base for photobiomodulation in veterinary medicine has grown considerably in recent years. Multiple peer-reviewed studies have demonstrated statistically significant reductions in pain markers and improvements in mobility in dogs with osteoarthritis following consistent PBM treatment. The American Association of Veterinary Laser Surgery has formally recognised photobiomodulation as a valid therapeutic modality for pain and inflammation in animals.
What’s important to understand is that red light therapy doesn’t reverse joint damage — no treatment currently can. What it does is address the inflammation and cellular dysfunction that make arthritis painful, which translates to real functional improvement: better mobility, more comfortable sleep, greater willingness to exercise, and in many cases, reduced reliance on NSAIDs and their associated long-term risks to kidney and liver function.
For pet owners researching structured, evidence-informed approaches to dog arthritis pain relief, Medcovet’s clinical education library provides some of the most thorough, vet-reviewed guidance available online — covering how photobiomodulation fits into a comprehensive treatment plan alongside medication, weight management, and physical rehabilitation.
At-Home Treatment vs Clinic Sessions: Is There a Difference?
Red light therapy has traditionally been administered in veterinary clinics and rehabilitation centres. The limitation is frequency: clinical sessions are typically once a week or less, partly due to cost and partly due to scheduling. But research on photobiomodulation suggests that consistent, regular treatment produces better outcomes than infrequent sessions — which is where at-home devices have changed the equation.
Not all at-home devices are equivalent. Consumer light panels marketed for general wellness are not the same as veterinary-grade devices designed for specific therapeutic wavelengths, dosage parameters, and tissue penetration depth. The distinction matters — a device that doesn’t reach the relevant tissue depth simply won’t produce the clinical outcomes that peer-reviewed studies demonstrate.
Medcovet’s Luma device was specifically developed for this gap — bringing veterinary-grade wavelengths (635nm and 850nm) and a patent-pending optical comb that parts fur to ensure direct skin contact and optimal light penetration into an at-home format. It’s trusted by over 250 veterinary clinics and rehab specialists, and every treatment plan is built by licensed veterinary clinicians for the individual dog’s specific condition and stage. The result is clinic-quality treatment on the frequency that actually produces results.
Where Red Light Therapy Fits in an Arthritis Management Plan
Red light therapy works best as part of a multimodal approach rather than as a standalone treatment. For most arthritic dogs, that means combining it with:
• Weight management. Every extra pound increases joint stress. For arthritic dogs, bringing weight to an appropriate range often produces more noticeable mobility improvement than any single treatment.
• Veterinary-prescribed medication when needed. NSAIDs remain the first-line pharmaceutical option for moderate-to-severe arthritis pain. Red light therapy is complementary — not a replacement for medication in dogs with significant pain.
• Low-impact exercise. Gentle, consistent movement maintains muscle mass and joint function better than rest. Short, regular walks are more beneficial than occasional longer ones.
• Joint supplements. Omega-3 fatty acids and certain glycosaminoglycan supplements have supporting evidence for joint health and work alongside PBM without conflict.
The strongest outcomes come from plans built around the individual dog — which is why Medcovet’s model of pairing the Luma device with a personalised plan from a licensed veterinary clinician makes more clinical sense than simply buying a light and guessing at protocols.
Conclusion
Red light therapy is not a miracle cure and it won’t reverse joint damage that’s already occurred. But the evidence that it reduces inflammation, improves cellular function in damaged joint tissue, and meaningfully improves mobility and pain levels in arthritic dogs is genuine and well-supported. For dogs where long-term NSAID use is a concern — due to age, kidney function, or owner preference for a lower-medication approach — it’s one of the most clinically credible non-drug options available.
If your dog is slowing down and you’re trying to understand what’s actually worth doing about it, the most useful starting point is a conversation with someone who can assess the individual case rather than a generic recommendation. That’s exactly the kind of free consult Medcovet provides — licensed veterinary clinicians who can tell you honestly whether red light therapy fits your dog’s situation, and what a realistic treatment plan would look like.
